http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020096440-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1120d995ed76f52ba263e0d71cee10c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972ee1d1051dbb3f93f628e9e6adcb94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_211144284fcf0c56aa47883dc9a89f57 |
publicationDate | 2002-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20020096440-A |
titleOfInvention | Controlled release formulation containing Apomophine for oral |
abstract | The present invention granulates apomorphine and its salts, stabilizers and anti-emetics together with other excipients, and sprays the coating solution at high speed while floating it under low temperature, while floating the coating powder thus formed under low temperature. Secondary spraying of the coating solution to form apomorphine granules, primary coating granules and secondary coating granules with different drug release rates, and by mixing them in a fixed ratio, by oral administration, the drug absorption rate is controlled to reduce side effects. It relates to apomorphine controlled release oral preparations and a method for preparing the same. |
priorityDate | 2001-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.